Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients.

Objectives: Cardiovascular disease worsens the prognosis of rheumatoid arthritis (RA) and vice-versa. Inflammation may be a common pathway for both conditions. It is expected that a longer RA duration leads to a greater inflammatory cumulative exposure burden; however, studies on the association between RA disease duration and outcomes are scarce.

Clinical associations and prognostic implications of 6-minute walk test in rheumatoid arthritis.

The clinical associations and prognostic implications of the 6-minute walk test (6MWT) distance in patients with rheumatoid arthritis (RA) is yet to be explored. To identify the clinical features and prognostic implications associated with the 6MWT in patients with RA. Cohort study including 387 RA patients who underwent 6MWT.

Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study.

Objectives: Differences in proteomic profiles between men and women may provide insights into the biological pathways that contribute to known sex differences in rheumatoid arthritis (RA). Studies focusing on sex differences in circulating proteins in RA patients are scarce. Our objective was to investigate the sex differences in circulating proteins of RA patients.

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis.

Rheumatoid arthritis (RA) increases the risk for abnormalities of the cardiac structure and function, which may lead to heart failure (HF). Studying the association between circulating biomarkers and echocardiographic parameters is important to screen patients with RA with a higher risk of cardiac dysfunction. To study the association between circulating biomarkers and echocardiographic parameters in patients with RA.

Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study.

Background: Rheumatoid arthritis (RA) patients have high risk of heart failure (HF).

Aims: Identifying the risk factors and mechanistic pathways associated with HF in patients with RA.

Methods: Cohort study enrolling 355 RA patients.